{"schema_version":"secwatch.filing_event.v1","accession":"0000275053-21-000015","form_type":"8-K/A","ticker":"NATR","cik":"0000275053","company_name":"NATURES SUNSHINE PRODUCTS INC","filed_at":"2021-07-12T23:59:59+00:00","discovered_at":"2026-05-14T18:04:20.242820+00:00","generated_at":"2026-06-30T06:12:59.394554+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Nature's Sunshine Q3 2020: Record net sales $100.3M (+13% YoY); net income $7.2M vs $1.4M","bullets":["GAAP net income $7.2M ($0.34 diluted EPS) vs $1.4M ($0.07) a year ago; adjusted EPS also $0.34.","Record net sales of $100.3M, up 13% YoY; all operating segments grew with Europe leading at +23%.","Adjusted EBITDA up 13% to $9.4M; SG&A as % of sales improved 200 bps to 33.2%.","Cash and equivalents $82.3M, total debt $5.4M; operating cash flow $26.8M YTD vs $5.5M prior.","CEO cites strong demand, new product launches, ease of COVID restrictions in key markets."],"urls":{"canonical":"https://secwatch.observer/filing/0000275053-21-000015","json":"https://secwatch.observer/filing/0000275053-21-000015.json","markdown":"https://secwatch.observer/filing/0000275053-21-000015.md","text":"https://secwatch.observer/filing/0000275053-21-000015.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/275053/000027505321000015/0000275053-21-000015-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/275053/000027505321000015/natr-20201109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T06:12:59.394554+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}